Luyan Pharma Co.,Ltd. (002788.SZ)

CNY 8.05

(0.25%)

EBITDA Summary of Luyan Pharma Co.,Ltd.

Luyan Pharma Co.,Ltd.'s latest annual EBITDA in 2023 was 819.73 Million CNY , down -1.61% from previous year.
Luyan Pharma Co.,Ltd.'s latest quarterly EBITDA in 2024 Q3 was 150.22 Million CNY , down -34.38% from previous quarter.
Luyan Pharma Co.,Ltd. reported an annual EBITDA of 807.92 Million CNY in 2022, up 12.58% from previous year.
Luyan Pharma Co.,Ltd. reported an annual EBITDA of 712.04 Million CNY in 2021, up 19.03% from previous year.
Luyan Pharma Co.,Ltd. reported a quarterly EBITDA of 227.71 Million CNY for 2024 Q2, up 46.46% from previous quarter.
Luyan Pharma Co.,Ltd. reported a quarterly EBITDA of 150.22 Million CNY for 2024 Q3, down -34.38% from previous quarter.

Annual EBITDA Chart of Luyan Pharma Co.,Ltd. (2023 - 2011)

Historical Annual EBITDA of Luyan Pharma Co.,Ltd. (2023 - 2011)

Year	EBITDA	EBITDA Growth
2023	819.73 Million CNY	-1.61%
2022	807.92 Million CNY	12.58%
2021	712.04 Million CNY	19.03%
2020	591.39 Million CNY	8.07%
2019	546.34 Million CNY	35.6%
2018	432.47 Million CNY	38.51%
2017	312.47 Million CNY	26.28%
2016	239.84 Million CNY	-3.63%
2015	254.18 Million CNY	3.53%
2014	245.68 Million CNY	11.35%
2013	220.41 Million CNY	30.13%
2012	171.8 Million CNY	56.99%
2011	109.43 Million CNY	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	171.59 Million CNY	-37.89%
2024 Q2	227.71 Million CNY	46.46%
2024 Q3	150.22 Million CNY	-34.38%
2023 Q2	189.44 Million CNY	14.59%
2023 Q4	222.4 Million CNY	56.99%
2023 FY	- CNY	-1.61%
2023 Q3	141.66 Million CNY	-25.22%
2023 Q1	165.31 Million CNY	-28.78%
2022 Q3	158.17 Million CNY	-18.72%
2022 FY	- CNY	12.58%
2022 Q4	232.12 Million CNY	46.76%
2022 Q2	194.59 Million CNY	25.11%
2022 Q1	155.54 Million CNY	-16.46%
2021 FY	- CNY	19.03%
2021 Q3	153.24 Million CNY	-9.08%
2021 Q4	186.18 Million CNY	21.5%
2021 Q2	168.54 Million CNY	22.92%
2021 Q1	137.11 Million CNY	-6.63%
2020 Q3	156.68 Million CNY	-3.19%
2020 Q2	161.84 Million CNY	40.82%
2020 FY	- CNY	8.07%
2020 Q1	114.93 Million CNY	-16.93%
2020 Q4	146.84 Million CNY	-6.28%
2019 Q3	138.78 Million CNY	-12.34%
2019 FY	- CNY	35.6%
2019 Q2	158.31 Million CNY	56.57%
2019 Q1	101.11 Million CNY	-1.44%
2019 Q4	138.36 Million CNY	-0.3%
2018 Q2	96.05 Million CNY	4.51%
2018 Q4	102.59 Million CNY	3.16%
2018 FY	- CNY	38.51%
2018 Q3	99.44 Million CNY	3.54%
2018 Q1	91.9 Million CNY	37.63%
2017 Q1	47.77 Million CNY	26.28%
2017 FY	- CNY	26.28%
2017 Q3	88.35 Million CNY	18.68%
2017 Q4	66.77 Million CNY	-24.43%
2017 Q2	74.44 Million CNY	55.83%
2016 Q1	49.45 Million CNY	-23.62%
2016 Q2	69.41 Million CNY	40.35%
2016 Q4	37.83 Million CNY	-35.15%
2016 FY	- CNY	-3.63%
2016 Q3	58.33 Million CNY	-15.96%
2015 Q4	64.75 Million CNY	4.89%
2015 Q1	53.22 Million CNY	0.0%
2015 Q3	61.73 Million CNY	-9.02%
2015 FY	- CNY	3.53%
2015 Q2	67.85 Million CNY	27.49%
2014 FY	- CNY	11.35%
2013 FY	- CNY	30.13%
2012 FY	- CNY	56.99%
2011 FY	- CNY	0.0%

Peer EBITDA Comparison of Luyan Pharma Co.,Ltd.

Name	EBITDA	EBITDA Difference
Cachet Pharmaceutical Co., Ltd.	912.84 Million CNY	10.2%
Yixintang Pharmaceutical Group Co., Ltd.	2.18 Billion CNY	62.434%
ZJAMP Group Co., Ltd.	1.51 Billion CNY	45.893%
Ji Yao Holding Group Co., Ltd.	-225.02 Million CNY	464.284%